SNFs prepare to absorb nearly $800 million in Medicare cuts

Alan Rosenbloom, president and CEO of The Alliance for Quality Nursing Home Care
Alan Rosenbloom, president and CEO of The Alliance for Quality Nursing Home Care

Medicare cuts scheduled to hit in January will cost skilled nursing facilities close to $800 million in fiscal year 2014, a new analysis estimates.

Under the Budget Control Act, the mandated 2% across-the-board Medicare cuts would hit skilled nursing facilities in California, Florida, Texas, New York, Illinois, New Jersey, Ohio, Pennsylvania, Michigan and Massachusetts the hardest, according to a analysis from Avalere Health and the Alliance for Quality Nursing Home Care. The cuts would total $782.3 million.

But SNFS will also have to absorb at least $3 billion over the next decade from “bad-debt” provisions, leaving the sector slated to absorb a total of $48 billion in funding losses between fiscal years 2012 and 21, the groups stated.

“Demographic reality and the rapidly evolving nature of our patient population requires a more rational, cost-effective Medicare post-acute payment system-- not more irrational Medicare cuts that jeopardize ongoing access to quality care,” Alan G. Rosenbloom, the president of the Alliance for Quality Nursing Home Care, said in a statement.

Click here for more analysis.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.